Project Details
| Short title | An Open, Phase two trial of the efficacy and safety of ISIS 2503 in women with metastatic breast cancer. |
|---|---|
| Status | Finished |
| Effective start/end date | 1/11/00 → 31/10/02 |
Funding
- ISIS PHARMACEUTICALS INC
An Open, Phase two trial of the efficacy and safety of ISIS 2503 in women with metastatic breast cancer.
- Rea, Daniel (Principal Investigator)